CBER Director Peter Marks (Greg Nash/Pool via AP Images)

FDA hopes to sim­pli­fy and stan­dard­ize Covid shots with­out mak­ing them in­ter­change­able

The FDA’s ad­vi­so­ry com­mit­tee of out­side vac­cine ex­perts will meet Thurs­day to dis­cuss how to sim­pli­fy the Covid-19 vac­ci­na­tion process, make the strain se­lec­tion process eas­i­er and more reg­u­lar, and de­cide whether to use the same strain for both the pri­ma­ry and boost­er dos­es.

But de­spite a de­sire by the agency to sim­pli­fy the vac­ci­na­tion pro­duc­tion and ad­min­is­tra­tion process, the agency ac­knowl­edged that, for now, it may be chal­leng­ing to har­mo­nize dif­fer­ent vac­cines from Mod­er­na and Pfiz­er/BioN­Tech in­to a sin­gle, in­ter­change­able shot.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.